Smartphone- and internet-assisted self-management and adherence tools to manage Parkinson’s disease (SMART-PD): study protocol for a randomised controlled trial (v7; 15 August 2014)

Abstract

BackgroundNonadherence to treatment leads to suboptimal treatment outcomes and enormous costs to the economy. This is especially important in Parkinson’s disease (PD). The progressive nature of the degenerative process, the complex treatment regimens and the high rates of comorbid conditions make treatment adherence in PD a challenge. Clinicians have limited face-to-face consultation time with PD patients, making it difficult to comprehensively address non-adherence. The rapid growth of digital technologies provides an opportunity to improve adherence and the quality of decision-making during consultation. The aim of this randomised controlled trial (RCT) is to evaluate the impact of using a smartphone and web applications to promote patient self-management as a tool to increase treatment adherence and working with the data collected to enhance the quality of clinical consultation.Methods/DesignA 4-month multicentre RCT with 222 patients will be conducted to compare use of a smartphone- and internet-enabled Parkinson’s tracker smartphone app with treatment as usual for patients with PD and/or their carers. The study investigators will compare the two groups immediately after intervention. Seven centres across England (6) and Scotland (1) will be involved. The primary objective of this trial is to assess whether patients with PD who use the app show improved medication adherence compared to those receiving treatment as usual alone. The secondary objectives are to investigate whether patients who receive the app and those who receive treatment as usual differ in terms of quality of life, quality of clinical consultation, overall disease state and activities of daily living. We also aim to investigate the experience of those receiving the intervention by conducting qualitative interviews with a sample of participants and clinicians, which will be administered by independent researchers.Trial registrationISRCTN45824264 (registered 5 November 2013)Electronic supplementary materialThe online version of this article (doi:10.1186/1745-6215-15-374) contains supplementary material, which is available to authorized users.

Quantitative Measurement of Akinesia in Parkinson's Disease

“…Most of those systems are relatively invasive and time consuming and do not differentiate normal movement from tremor and high activity from dyskinesia . In the past few years, great interest has arisen in the use of smartphones application for the evaluation and treatment of patients with PD …”

Cloudy with a Chance of Pain: Engagement and Subsequent Attrition of Daily Data Entry in a Smartphone Pilot Study Tracking Weather, Disease Severity, and Physical Activity in Patients With Rheumatoid Arthritis

“…Participants discussed multiple topics including beliefs about associations between weather and joint pain, existing views and experiences on the use of smartphones and other digital technologies, and views about recording symptoms for use in research. A preexisting health-monitoring smartphone app, designed by uMotif (a digital health company) and known to have high patient engagement [12], was then introduced using a brief film to prompt discussion and feedback [13]. Patients’ views were sought on the design, usability, and variables to be recorded.…”

Lessons learned in the development and evaluation of RxCoach™, an mHealth app to increase tobacco cessation medication adherence

“…Adherence to prescribed treatment is necessary to achieve desired health outcomes; however, studies have shown that 30% – 50% of patients do not take medications as prescribed [9–13]. Non-adherence to medication for chronic conditions has been associated with poor treatment outcomes, including increasing hospitalization rates and health care costs [11, 12, 14]. Conversely, research has found a dose-response between treatment adherence and positive health outcomes [3, 4, 12, 15, 16].…”